PubMed:33407777 / 0-188
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 4 | 109-117 | Species | denotes | patients | Tax:9606 |
| 5 | 123-158 | Disease | denotes | acute respiratory distress syndrome | MESH:D012128 |
| 6 | 166-174 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 7 | 176-184 | Disease | denotes | COVID-AT | MESH:C000657245 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 129-149 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-186 | Sentence | denotes | Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): |